Drug Discovery App CS WP
-
Excellence In Peptide And Oligonucleotide Purification
11/5/2025
Explore how digital tools are advancing peptide purification, with a focus on GLP-1 receptor agonists, as well as how process efficiency can be accelerated through real-time insights.
-
Simple Orchestration Of Multiple Unit Operations
11/5/2025
Gain insight into how consolidating downstream operations into a single automated system can reduce footprint, cut processing time, and minimize manual errors to help teams work more efficiently.
-
An Efficient End-To-End AAV8 Platform Process
11/5/2025
Explore a scalable AAV production platform that improves full capsid yield and dramatically reduces host cell impurities, offering a practical solution to common manufacturing challenges.
-
Tools For Efficient And Reliable Gene Therapy Manufacturing
11/5/2025
Discover scalable strategies for overcoming AAV purification challenges, from low yield and impurity removal to serotype variability, as well as how advanced tools can streamline manufacturing.
-
Enabling The Future Of Intensified Biomanufacturing
11/5/2025
Process intensification demands smarter orchestration, real-time analytics, and scalable automation. Discover how digital infrastructure enables synchronized, compliant, and predictive biomanufacturing.
-
A Risk-Based Approach To Plasmid DNA And mRNA Process Development
9/23/2025
Balancing robust analytics and clinical readiness is key for early-phase pDNA and mRNA therapeutics amid structural complexity and regulatory challenges.
-
Characterize Your PROTAC Hook Effect With Flexible In-Solution Affinity Measurements
9/3/2025
Characterizing the PROTAC hook effect is crucial for selecting candidates with enhanced cooperativity. Gain confidence with flexible, in-solution affinity measurements that reveal key biophysical parameters and align with established three-component binding models.
-
Time To Intensify: Taking mAb Manufacturing To The Next Level
8/19/2025
Explore how process intensification can revolutionize monoclonal antibody manufacturing to boost productivity, cut costs, and enhance sustainability with scalable strategies and real-world results.
-
Cell Line Development For Bispecific Antibodies
8/18/2025
See how the recently described cell line development paradigm shift, enabled by the Leap-In transposon platform, can extend to the development of bispecific monoclonal antibody-producing cell substrates.
-
Zero To Final Fill: How HUGEL Implemented Its First Single-Use Lines
8/6/2025
As regulations tighten, biomanufacturers are adopting single-use tech to boost compliance, reduce labor, and streamline fill-finish operations from the ground up.